US Stock MarketDetailed Quotes

Adagio Medical (ADGM)

Watchlist
  • 0.9709
  • -0.0091-0.93%
Close May 6 16:00 ET
  • 0.9707
  • -0.0002-0.02%
Post 16:58 ET
21.56MMarket Cap-0.64P/E (TTM)

Adagio Medical (ADGM) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
254K
-56.67%26K
58.73%300K
78K
Operating revenue
--0
--0
--0
--0
--0
----
--254K
-56.67%26K
58.73%300K
--78K
Cost of revenue
684K
58K
31K
-49.85%342K
-53.32%253K
682K
70.44%542K
49.26%1.31M
14.78%334K
Gross profit
-684K
-58K
-31K
20.09%-342K
50.97%-253K
-428K
-100.00%-516K
-46.65%-1.01M
12.03%-256K
Operating expense
21.21M
3.91M
5.69M
-29.79%4.38M
-13.92%7.14M
6.23M
29.75%8.3M
15.97%26.94M
-14.20%5.08M
Selling and administrative expenses
--10.57M
--1.68M
--2.92M
-28.58%2.4M
-27.85%3.49M
----
--3.37M
202.25%4.83M
114.76%11.54M
125.77%3.3M
Research and development costs
--10.64M
--2.24M
--2.77M
-31.20%1.97M
5.48%3.66M
----
--2.87M
-27.70%3.47M
-13.76%15.4M
-60.17%1.77M
Operating profit
-21.89M
-3.97M
-5.72M
29.16%-4.72M
16.09%-7.4M
-6.66M
-32.48%-8.82M
-16.85%-27.94M
14.09%-5.33M
Net non-operating interest income expense
-2.43M
-643K
-670K
18.47%-618K
33.86%-498K
-758K
-224.57%-753K
-1,589.80%-1.66M
-333.08%-576K
Non-operating interest income
--477K
--132K
--79K
5,000.00%102K
16,300.00%164K
----
--2K
0.00%1K
-92.31%3K
-75.00%1K
Non-operating interest expense
--2.91M
--775K
--749K
-5.26%720K
-12.20%662K
----
--760K
223.61%754K
1,110.95%1.66M
321.17%577K
Other net income (expense)
-765K
1.31M
-3.73M
-17.53%1.39M
-88.26%182K
1.68M
164.85%1.55M
-2,628.99%-8.55M
-1,481.23%-4.27M
Gain on sale of security
--20K
--354K
---231K
-250.00%-141K
147.50%38K
----
--94K
-142.42%-80K
---42K
--41K
Special income (charges)
--0
----
----
----
----
----
----
----
----
----
-Less:Impairment of capital assets
--0
----
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
---785K
--951K
---3.5M
-3.78%1.53M
-91.17%144K
----
--1.59M
169.16%1.63M
-2,616.57%-8.51M
-1,494.50%-4.31M
Income before tax
-25.08M
-3.31M
-10.12M
31.16%-3.95M
3.80%-7.71M
-5.73M
13.56%-8.02M
-61.14%-38.15M
-68.72%-10.18M
Income tax
Net income
-25.08M
-3.31M
-10.12M
31.16%-3.95M
3.80%-7.71M
-5.73M
13.56%-8.02M
-61.14%-38.15M
-68.72%-10.18M
Net income continuous Operations
---25.08M
---3.31M
---10.12M
31.16%-3.95M
3.80%-7.71M
----
---5.73M
13.56%-8.02M
-61.14%-38.15M
-68.72%-10.18M
Minority interest income
Net income attributable to the parent company
-25.08M
-3.31M
-10.12M
31.16%-3.95M
3.80%-7.71M
-5.73M
13.56%-8.02M
-61.14%-38.15M
-68.72%-10.18M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-25.08M
-3.31M
-10.12M
31.16%-3.95M
3.80%-7.71M
-5.73M
13.56%-8.02M
-61.14%-38.15M
-68.72%-10.18M
Basic earnings per share
-1.51
-0.16
-0.66
39.30%-0.26
16.52%-0.5
-0.4283
13.56%-0.5989
-61.14%-2.8493
-68.72%-0.7602
Diluted earnings per share
-1.51
-0.21
-0.66
18.28%-0.35
14.85%-0.51
-0.4283
13.56%-0.5989
-61.14%-2.8493
-68.72%-0.7602
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 00000254K-56.67%26K58.73%300K78K
Operating revenue --0--0--0--0--0------254K-56.67%26K58.73%300K--78K
Cost of revenue 684K58K31K-49.85%342K-53.32%253K682K70.44%542K49.26%1.31M14.78%334K
Gross profit -684K-58K-31K20.09%-342K50.97%-253K-428K-100.00%-516K-46.65%-1.01M12.03%-256K
Operating expense 21.21M3.91M5.69M-29.79%4.38M-13.92%7.14M6.23M29.75%8.3M15.97%26.94M-14.20%5.08M
Selling and administrative expenses --10.57M--1.68M--2.92M-28.58%2.4M-27.85%3.49M------3.37M202.25%4.83M114.76%11.54M125.77%3.3M
Research and development costs --10.64M--2.24M--2.77M-31.20%1.97M5.48%3.66M------2.87M-27.70%3.47M-13.76%15.4M-60.17%1.77M
Operating profit -21.89M-3.97M-5.72M29.16%-4.72M16.09%-7.4M-6.66M-32.48%-8.82M-16.85%-27.94M14.09%-5.33M
Net non-operating interest income expense -2.43M-643K-670K18.47%-618K33.86%-498K-758K-224.57%-753K-1,589.80%-1.66M-333.08%-576K
Non-operating interest income --477K--132K--79K5,000.00%102K16,300.00%164K------2K0.00%1K-92.31%3K-75.00%1K
Non-operating interest expense --2.91M--775K--749K-5.26%720K-12.20%662K------760K223.61%754K1,110.95%1.66M321.17%577K
Other net income (expense) -765K1.31M-3.73M-17.53%1.39M-88.26%182K1.68M164.85%1.55M-2,628.99%-8.55M-1,481.23%-4.27M
Gain on sale of security --20K--354K---231K-250.00%-141K147.50%38K------94K-142.42%-80K---42K--41K
Special income (charges) --0------------------------------------
-Less:Impairment of capital assets --0------------------------------------
Other non- operating income (expenses) ---785K--951K---3.5M-3.78%1.53M-91.17%144K------1.59M169.16%1.63M-2,616.57%-8.51M-1,494.50%-4.31M
Income before tax -25.08M-3.31M-10.12M31.16%-3.95M3.80%-7.71M-5.73M13.56%-8.02M-61.14%-38.15M-68.72%-10.18M
Income tax
Net income -25.08M-3.31M-10.12M31.16%-3.95M3.80%-7.71M-5.73M13.56%-8.02M-61.14%-38.15M-68.72%-10.18M
Net income continuous Operations ---25.08M---3.31M---10.12M31.16%-3.95M3.80%-7.71M-------5.73M13.56%-8.02M-61.14%-38.15M-68.72%-10.18M
Minority interest income
Net income attributable to the parent company -25.08M-3.31M-10.12M31.16%-3.95M3.80%-7.71M-5.73M13.56%-8.02M-61.14%-38.15M-68.72%-10.18M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -25.08M-3.31M-10.12M31.16%-3.95M3.80%-7.71M-5.73M13.56%-8.02M-61.14%-38.15M-68.72%-10.18M
Basic earnings per share -1.51-0.16-0.6639.30%-0.2616.52%-0.5-0.428313.56%-0.5989-61.14%-2.8493-68.72%-0.7602
Diluted earnings per share -1.51-0.21-0.6618.28%-0.3514.85%-0.51-0.428313.56%-0.5989-61.14%-2.8493-68.72%-0.7602
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes------------------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
The negotiations between the US and Iran have entered a critical window amid external expectations and various parties' maneuvering, with th Show More